Literature DB >> 33580115

Prognostic value of cardio-hepatic-skeletal muscle syndrome in patients with heart failure.

Takumi Noda1, Kentaro Kamiya2,3, Nobuaki Hamazaki4, Kohei Nozaki4, Takafumi Ichikawa4, Takeshi Nakamura1, Masashi Yamashita1, Shota Uchida1, Emi Maekawa5, Jennifer L Reed6,7,8, Minako Yamaoka-Tojo1,9, Atsuhiko Matsunaga1,9, Junya Ako5.   

Abstract

Although heart failure (HF) and liver dysfunction often coexist because of complex cardiohepatic interactions, the association between liver dysfunction and physical dysfunction, and between coexistence of both and prognosis in HF patients remains unclear. We reviewed 895 patients with HF (mean age, 69.4 ± 14.2 years) who underwent liver function test using model for end-stage liver disease excluding international normalized ratio (MELD-XI) score and physical function test (grip strength, leg strength, gait speed, and 6-min walking distance [6MWD]). In the multiple regression analysis, MELD-XI score was independently associated with lower grip strength, leg strength, gait speed, and 6MWD (all P < 0.001). One hundred thirty deaths occurred over a median follow-up period of 1.67 years (interquartile range: 0.62-3.04). For all-cause mortality, patients with high MELD-XI scores and reduced physical functions were found to have a significantly higher mortality risk even after adjusting for several covariates (grip strength, hazard ratio [HR]: 3.80, P < 0.001; leg strength, HR: 4.65, P < 0.001; gait speed, HR: 2.49, P = 0.001, and 6MWD, HR: 5.48, P < 0.001). Liver dysfunction was correlated with reduced physical function. Moreover, the coexistence of lower physical function and liver dysfunction considerably affected prognosis in patients with HF.

Entities:  

Mesh:

Year:  2021        PMID: 33580115      PMCID: PMC7880995          DOI: 10.1038/s41598-020-80641-2

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  33 in total

1.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

2.  Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury.

Authors:  Hao Wang; Yu Tina Zhao; Shouyan Zhang; Patrycja M Dubielecka; Jianfeng Du; Naohiro Yano; Y Eugene Chin; Shougang Zhuang; Gangjian Qin; Ting C Zhao
Journal:  J Cell Physiol       Date:  2017-05-03       Impact factor: 6.384

Review 3.  Protective Roles of Adipocytokines and Myokines in Cardiovascular Disease.

Authors:  Noriyuki Ouchi; Koji Ohashi; Rei Shibata; Toyoaki Murohara
Journal:  Circ J       Date:  2016-09-01       Impact factor: 2.993

4.  Physical Function and Strength in Relation to Inflammation in Older Adults with Obesity and Increased Cardiometabolic Risk.

Authors:  J Tay; A M Goss; J L Locher; J D Ard; B A Gower
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

Review 5.  Nutrition and Muscle in Cirrhosis.

Authors:  Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2017-11-08

6.  A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.

Authors:  Jeroen Laurens Ad van Vugt; Louise Johanna Maria Alferink; Stefan Buettner; Marcia Patricia Gaspersz; Daphne Bot; Sarwa Darwish Murad; Shirin Feshtali; Peter Martinus Adranius van Ooijen; Wojciech Grzegorz Polak; Robert Jack Porte; Bart van Hoek; Aad Pieter van den Berg; Herold J Metselaar; Jan Nicolaas Maria IJzermans
Journal:  J Hepatol       Date:  2017-12-06       Impact factor: 25.083

Review 7.  Exercise Intolerance in Patients With Heart Failure: JACC State-of-the-Art Review.

Authors:  Marco Giuseppe Del Buono; Ross Arena; Barry A Borlaug; Salvatore Carbone; Justin M Canada; Danielle L Kirkman; Ryan Garten; Paula Rodriguez-Miguelez; Marco Guazzi; Carl J Lavie; Antonio Abbate
Journal:  J Am Coll Cardiol       Date:  2019-05-07       Impact factor: 24.094

Review 8.  Branched-chain amino acids for people with hepatic encephalopathy.

Authors:  Lise Lotte Gluud; Gitte Dam; Iñigo Les; Giulio Marchesini; Mette Borre; Niels Kristian Aagaard; Hendrik Vilstrup
Journal:  Cochrane Database Syst Rev       Date:  2017-05-18

9.  Survival after the onset of congestive heart failure in Framingham Heart Study subjects.

Authors:  K K Ho; K M Anderson; W B Kannel; W Grossman; D Levy
Journal:  Circulation       Date:  1993-07       Impact factor: 29.690

10.  Irisin alleviates liver ischemia-reperfusion injury by inhibiting excessive mitochondrial fission, promoting mitochondrial biogenesis and decreasing oxidative stress.

Authors:  Jianbin Bi; Jia Zhang; Yifan Ren; Zhaoqing Du; Qingshan Li; Yue Wang; Shasha Wei; Lifei Yang; Jingyao Zhang; Chang Liu; Yi Lv; Rongqian Wu
Journal:  Redox Biol       Date:  2018-10-24       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.